Skip to content
Global Vascular Guideline on the Management of Patients with CLTI Webinar Pre-Questions
*
1.
Name
(Required.)
*
2.
Email
(Required.)
*
3.
Do you evaluate cardiovascular risk factors for suspected CLTI patients
(check all that apply)
(Required.)
Family history
Smoking
Cholesterol
BMI
Diabetes
Do not evaluate
*
4.
Do you counsel your patients on any of the following:
(check all that apply)
(Required.)
Smoking cessation
Control BP
Diet
Exercise
Diabetes management
Preventive foot care
Do not counsel
*
5.
Do you routinely evaluate your CLTI patients using classification system?
(Required.)
Yes
No
*
6.
Which of the following classification system do you use currently for staging your patients? (check all that apply)
(Required.)
WIfI
GLASS
Rutherford/Fontaine
Wagner
Other
Do not stage
*
7.
How confident are you using the staging systems?
(Required.)
Very confident
Confident
Somewhat confident
Not confident
*
8.
How helpful do you find the staging system in your clinical practice?
(Required.)
Very helpful
Helpful
Somewhat helpful
Not helpful
*
9.
Which of the following do you currently use to assess the severity of CLTI in your patients?
(check all that apply)
(Required.)
Ankle pressure
Toe pressure
ABI
ASP
Pain
TcpO2
Other
Do not assess
*
10.
How confident are you in assessing the severity of your CLTI patients?
(Required.)
Very confident
Confident
Somewhat confident
Not confident
*
11.
Do you prescribe your CLTI patients any of the following?
(Required.)
Statins
Antithrombotic
Antihypertensive
Antiplatelet
Glycemic control agents
*
12.
How confident are you in prescribing your CLTI patients statins?
(Required.)
Very confident
confident
Somewhat confident
Not confident
*
13.
Which of the following do you currently use to assess the quality of life in your CLTI patients ?
(check all that apply)
(Required.)
VascuQoL-6 (VQ-6)
VascuQoL-25
Short Form-36
Other
Do not assess
*
14.
How confident are you in assessing the quality of life in your patients with CLTI?
(Required.)
Very confident
Confident
Somewhat confident
Not confident
*
15.
Do you currently include patients in the development of their treatment plan?
(Required.)
Yes
No
Uncertain
*
16.
A 74 year-old woman weighing 55 kg presents to your office with hypertension, hyperlipidemia and intermittent, nocturnal rest pain. She does not have an ulcer, gangrene or any signs of foot infection She is on antihypertensive therapy, high dose statin, and antiplatelet therapy. Her BP is 118/68 and her most recent LDL is 65. You consider this patient’s medical management to be:
(Required.)
Optimal and candidate for discontinuation of antihypertensive therapy
Optimal and maintainable on current treatment regiment
Suboptimal but maintainable on current treatment
Suboptimal requiring additional or different treatment
Treatment failure requiring different treatment
*
17.
A 74 year-old woman recently developed a shallow distal toe ulcer with a small rim of cellulitis and no exposed bone. Her ABI is 0.79; toe pressure is 52 mm Hg. The correct WIfI classification, stage and amputation risk are:
(Required.)
WIfI: 211, Risk moderate, Stage 3
WIfI:111, Risk: low, Stage 2
WIfI: 211, Risk low, Stage 3
WIfI: 311, Risk high, Stage 4
*
18.
The GLASS system relies on the concept of a target artery path (TAP) selected by the treating physician after a diagnostic angiogram study has been obtained. Which of the following statements regarding the TAP are correct?
(Required.)
The superficial femoral and popliteal arteries are always part of the TAP in the GLASS system
The TAP should always include the tibial artery that appears least diseased in the calf
Either an angiosome-based or a non-angiosome based target artery may be selected for the TAP
GLASS staging is based on the overall complexity of the TAP from groin to ankle, from an endovascular perspective
The TAP for open bypass or endovascular intervention should always be the same
*
19.
How frequently have you utilized the SVS global guideline.
(Required.)
At least once a week
1 to 4 times per month
Every month or so
Less than 10 times during the year
I have not referenced the materials
*
20.
How frequently have you utilized the SVS global guideline based for pocket guides.
(Required.)
At least once a week
1 to 4 times per month
Every month or so
Less than 10 times during the year
I have not referenced the materials
*
21.
How frequently have you utilized the SVS global guideline calculators
(Required.)
At least once a week
1 to 4 times per month
Every month or so
Less than 10 times during the year
I have not referenced the materials